GlassScriptPhysician profile
Ashna Parti
NPI 1962459198
$2,420.61
in general payments reported to CMS, 2019-2025
24 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $171 · 2021: $852 · 2022: $164 · 2023: $330 · 2024: $194 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $716.92 | 2019-2023 | Proclaim, Eterna |
| Nevro Corp. | $410.15 | 2019-2021 | |
| Medtronic, INC. | $314.18 | 2021-2025 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.14 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $107.14 | 2025 | |
| Grt US Holding, INC. | $105.28 | 2021-2022 | |
| Globus Medical, INC. | $103.74 | 2025 | Senza |
| Biohaven Pharmaceuticals, INC. | $78.39 | 2021 | |
| Curonix LLC | $71.00 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $57.06 | 2023-2024 | Orthovisc |
| Sentynl Therapeutics, INC. | $38.22 | 2019 | |
| Arbor Pharmaceuticals, INC. | $35.86 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $33.75 | 2019-2021 | |
| Abbvie INC. | $26.58 | 2025 | |
| Daiichi Sankyo INC. | $16.56 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.64 | 2020 | |
| Redhill Biopharma INC. | $15.28 | 2020 | |
| Vertiflex, INC. | $14.00 | 2019 | |
| Avanos Medical | $13.94 | 2021 | |
| Horizon Therapeutics Plc | $12.41 | 2021 | |
| Amgen INC. | $11.78 | 2020 | |
| Allergan, INC. | $11.42 | 2020 | |
| Zyla Life Sciences, INC. | $11.15 | 2020 | |
| Assertio Therapeutics, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashna Parti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.